Bioxcel Therapeutics amended employment agreements for its top executives, reducing their cash compensation and granting stock options; Dr. Mehta's salary is now $706,558 with 660,000 options, CFO Steinhart's is $289,800 with 270,000 options, and CSO Yocca's is $290,500 with 270,000 options, all vesting over 12 months.